Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2011, Article ID 930965, 4 pages
http://dx.doi.org/10.4061/2011/930965
Clinical Study

Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children

1Urology-Nephrology and Transplantation Research Centre, Department of Paediatric Nephrology, Urmia University School of Medicine, Iran
2School of Medicine, Urmia University, Iran

Received 23 May 2011; Revised 17 July 2011; Accepted 18 July 2011

Academic Editor: R. Khanna

Copyright © 2011 A. A. Nikibakhsh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Filler, E. Young, P. Geier, B. Carpenter, A. Drukker, and J. Feber, “Is there really an increase in non-minimal change nephrotic syndrome in children?” American Journal of Kidney Diseases, vol. 42, no. 6, pp. 1107–1113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. G. Wang, Z. L. Zhou, T. Pan, C. C. Li, and Q. Yang, “Integrated traditional Chinese and Western medicine for infantile nephrotic syndrome-150 cases report,” Shanghai Journal of Traditional Chinese Medicine, vol. 2, pp. 27–29, 2002. View at Google Scholar
  3. K. D. McBryde, D. B. Kershaw, and W. E. Smoyer, “Pediatric steroid-resistant nephrotic syndrome,” Current Problems in Pediatric and Adolescent Health Care, vol. 31, no. 9, pp. 280–307, 2001. View at Google Scholar · View at Scopus
  4. R. Coppo, “Non-steroidal and non-cytotoxic therapies for nephrotic syndrome,” Nephrology Dialysis Transplantation, vol. 23, no. 6, pp. 1793–1796, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. L. Yu, Z. Y. Wen, S. D. Hua et al., “Analysis of clinical characteristics in infantile nephrotic syndrome,” Chinese Journal of Practical Pediatrics, vol. 17, pp. 553–555, 2002. View at Google Scholar
  6. E. M. Hodson, N. S. Willis, and J. C. Craig, “Non-corticosteroid treatment for nephrotic syndrome in children,” Cochrane Database of Systematic Reviews, vol. 23, no. 1, Article ID CD002290, 2008. View at Publisher · View at Google Scholar · View at PubMed
  7. P. D. Yorgin, J. Krasher, and A. Y. Al-Uzri, “Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome,” Pediatric Nephrology, vol. 16, no. 3, pp. 245–250, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. B. M. Tune, R. Kirpekar, R. K. Sibley, V. M. Reznik, W. R. Griswold, and S. A. Mendoza, “Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up,” Clinical Nephrology, vol. 43, no. 2, pp. 84–88, 1995. View at Google Scholar · View at Scopus
  9. C. D. A. Goonasekera, A. B. Koziell, S. A. Hulton, and M. J. Dillon, “Vincristine and focal segmental sclerosis: do we need a multicentre trial?” Pediatric Nephrology, vol. 12, no. 4, pp. 284–289, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Mendizábal, I. Zamora, O. Berbel, M. J. Sanahuja, J. Fuentes, and J. Simon, “Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome,” Pediatric Nephrology, vol. 20, no. 7, pp. 914–919, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. H. H. Ehrich, C. Geerlings, M. Zivicnjak, D. Franke, H. Geerlings, and J. Gellermann, “Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated,” Nephrology Dialysis Transplantation, vol. 22, no. 8, pp. 2183–2193, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. A. Segarra, J. Vila, L. Pou et al., “Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up,” Nephrology Dialysis Transplantation, vol. 17, no. 4, pp. 655–662, 2002. View at Google Scholar · View at Scopus
  13. I. Ejaz, H. I. Khan, B. K. Javaid, G. Rasool, and M. T. Bhatti, “Histopathological diagnosis and outcome of paediatric nephrotic syndrome,” Journal of the College of Physicians and Surgeons Pakistan, vol. 14, no. 4, pp. 229–233, 2004. View at Google Scholar · View at Scopus
  14. M. Del Rio and F. Kaskel, “Evaluation and management of steroid-unresponsive nephrotic syndrome,” Current Opinion in Pediatrics, vol. 20, no. 2, pp. 151–156, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. A. Kari and M. Halawani, “Treatment of steroid resistant nephrotic syndrome in children,” Saudi journal of kidney Diseases and Transplantation, vol. 21, no. 3, pp. 484–487, 2010. View at Google Scholar · View at Scopus
  16. I. Dubus, B. Vendrely, I. Christophe et al., “Mycophenolic acid antagonizes the activation of cultured human mesangial cells,” Kidney International, vol. 62, no. 3, pp. 857–867, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. Z. Li, C. Duan, J. He et al., “Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome,” Pediatric Nephrology, vol. 25, no. 5, pp. 883–888, 2099. View at Google Scholar
  18. E. M. Dorresteijn, J. E. Kist-van Holthe, E. N. Levtchenko, J. Nauta, W. C. J. Hop, and A. J. van der Heijden, “Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome,” Pediatric Nephrology, vol. 23, no. 11, pp. 2013–2020, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. D. Habashy, E. M. Hodson, and J. C. Craig, “Interventions for steroid-resistant nephrotic syndrome: a systematic review,” Pediatric Nephrology, vol. 18, no. 9, pp. 906–912, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. R. G. Ruf, A. Lichtenberger, S. M. Karle et al., “Patients with mutations in NPHS2 (Podocin) do not respond to standard steroid treatment of nephrotic syndrome,” Journal of the American Society of Nephrology, vol. 15, no. 3, pp. 722–732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. S. Gipson, K. Gibson, P. E. Gipson, S. Watkins, and M. Moxey-Mims, “Therapeutic approach to FSGS in children,” Pediatric Nephrology, vol. 22, no. 1, pp. 28–36, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. K. D. McBryde, D. B. Kershaw, and W. E. Smoyer, “Pediatric steroid-resistant nephrotic syndrome,” Current Problems in Pediatric, vol. 31, no. 9, pp. 275–307, 2001. View at Google Scholar · View at Scopus
  23. M. Bonilla-Felix, C. Parra, T. Dajani et al., “Changing patterns in the histopathology of idiopathic nephrotic syndrome in children,” Kidney International, vol. 55, no. 5, pp. 1885–1890, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. H. L. Barnett, C. M. Edelmann, and I. Greifer, “The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone,” Journal of Pediatrics, vol. 98, no. 4, pp. 561–564, 1981. View at Google Scholar · View at Scopus